메뉴 건너뛰기




Volumn 104, Issue 8, 2004, Pages 2254-2262

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHLORAMBUCIL; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

EID: 4944246445     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1506     Document Type: Article
Times cited : (225)

References (39)
  • 1
    • 0035383762 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
    • McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 2001;97:3390-3400.
    • (2001) Blood , vol.97 , pp. 3390-3400
    • McSweeney, P.A.1    Niederwieser, D.2    Shizuru, J.A.3
  • 2
    • 0037441604 scopus 로고    scopus 로고
    • Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases
    • Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood. 2003;101:1620-1629.
    • (2003) Blood , vol.101 , pp. 1620-1629
    • Niederwieser, D.1    Maris, M.2    Shizuru, J.A.3
  • 3
    • 10744222061 scopus 로고    scopus 로고
    • HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
    • Maris MB, Niederwieser D, Sandmaier BM, et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood. 2003;102:2021-2030.
    • (2003) Blood , vol.102 , pp. 2021-2030
    • Maris, M.B.1    Niederwieser, D.2    Sandmaier, B.M.3
  • 4
    • 0142152420 scopus 로고    scopus 로고
    • Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
    • Maloney DG, Molina AJ, Sahebi F, et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood. 2003;102: 3447-3454.
    • (2003) Blood , vol.102 , pp. 3447-3454
    • Maloney, D.G.1    Molina, A.J.2    Sahebi, F.3
  • 5
    • 0032006125 scopus 로고    scopus 로고
    • Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
    • Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756-763.
    • (1998) Blood , vol.91 , pp. 756-763
    • Slavin, S.1    Nagler, A.2    Naparstek, E.3
  • 6
    • 0030925301 scopus 로고    scopus 로고
    • Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
    • Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 1997;89:4531-4536.
    • (1997) Blood , vol.89 , pp. 4531-4536
    • Giralt, S.1    Estey, E.2    Albitar, M.3
  • 7
    • 0031879197 scopus 로고    scopus 로고
    • Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
    • Khouri IF, Keating M, Körbling M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16:2817-2824.
    • (1998) J Clin Oncol , vol.16 , pp. 2817-2824
    • Khouri, I.F.1    Keating, M.2    Körbling, M.3
  • 8
    • 0033642531 scopus 로고    scopus 로고
    • Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
    • Spitzer TR, McAfee S, Sackstein R, et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant. 2000;6:309-320.
    • (2000) Biol Blood Marrow Transplant , vol.6 , pp. 309-320
    • Spitzer, T.R.1    McAfee, S.2    Sackstein, R.3
  • 9
    • 0033230960 scopus 로고    scopus 로고
    • Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
    • Childs R, Clave E, Contentin N, et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood. 1999;94:3234-3241.
    • (1999) Blood , vol.94 , pp. 3234-3241
    • Childs, R.1    Clave, E.2    Contentin, N.3
  • 10
    • 0034307366 scopus 로고    scopus 로고
    • In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
    • Kottaridis PD, Milligan DW, Chopra R, et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood. 2000;96:2419-2425.
    • (2000) Blood , vol.96 , pp. 2419-2425
    • Kottaridis, P.D.1    Milligan, D.W.2    Chopra, R.3
  • 11
    • 0034885941 scopus 로고    scopus 로고
    • Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients
    • Bornhauser M, Thiede C, Platzbecker U, et al. Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer Res. 2001;7: 2254-2262.
    • (2001) Clin Cancer Res , vol.7 , pp. 2254-2262
    • Bornhauser, M.1    Thiede, C.2    Platzbecker, U.3
  • 12
    • 0037623948 scopus 로고    scopus 로고
    • Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival
    • Keil F, Prinz E, Moser K, et al. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Transplantation. 2003;76:230-236.
    • (2003) Transplantation , vol.76 , pp. 230-236
    • Keil, F.1    Prinz, E.2    Moser, K.3
  • 13
    • 0042160845 scopus 로고    scopus 로고
    • Low dose TBI conditioning for hematopoietic stem cell transplants (HSCT) from HLA-matched related donors for patients with hematologic malignancies: Influence of fludarabine or cytoreductive autografts on outcome
    • Abstract no. 544
    • Sandmaier BM, Maloney DG, Gooley TA, et al. Low dose TBI conditioning for hematopoietic stem cell transplants (HSCT) from HLA-matched related donors for patients with hematologic malignancies: influence of fludarabine or cytoreductive autografts on outcome [abstract]. Blood. 2002;100(pt 1):145a. Abstract no. 544.
    • (2002) Blood , vol.100 , Issue.PART 1
    • Sandmaier, B.M.1    Maloney, D.G.2    Gooley, T.A.3
  • 16
    • 0036660429 scopus 로고    scopus 로고
    • Therapy for chronic graft-versus-host disease: A randomized trial comparing cyclosporine plus prednisone versus prednisone alone
    • Koc S, Leisenring W, Flowers MED, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002;100:48-51.
    • (2002) Blood , vol.100 , pp. 48-51
    • Koc, S.1    Leisenring, W.2    Flowers, M.E.D.3
  • 17
    • 0036400055 scopus 로고    scopus 로고
    • Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study
    • Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant. 2002;8:512-520.
    • (2002) Biol Blood Marrow Transplant , vol.8 , pp. 512-520
    • Junghanss, C.1    Marr, K.A.2    Carter, R.A.3
  • 18
    • 0042243672 scopus 로고    scopus 로고
    • Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
    • Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102:827-833.
    • (2003) Blood , vol.102 , pp. 827-833
    • Fukuda, T.1    Boeckh, M.2    Carter, R.A.3
  • 19
    • 0026509756 scopus 로고
    • Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta Acpsi-2 (ACTBP2)
    • Polymeropoulos MH, Rath DS, Xiao H, Merril CR. Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta Acpsi-2 (ACTBP2). Nucleic Acids Res. 1992;20: 1432-1432.
    • (1992) Nucleic Acids Res , vol.20 , pp. 1432-1432
    • Polymeropoulos, M.H.1    Rath, D.S.2    Xiao, H.3    Merril, C.R.4
  • 20
    • 0026893558 scopus 로고
    • A further tetranucleotide repeat polymorphism in the vWF gene
    • Kimpton C, Walton A, Gill P. A further tetranucleotide repeat polymorphism in the vWF gene. Hum Mol Genet. 1992;1:287.
    • (1992) Hum Mol Genet , vol.1 , pp. 287
    • Kimpton, C.1    Walton, A.2    Gill, P.3
  • 21
    • 3042871056 scopus 로고
    • Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region
    • Boerwinkle E, Xiong WJ, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci U S A. 1989;86:212-216.
    • (1989) Proc Natl Acad Sci U S A , vol.86 , pp. 212-216
    • Boerwinkle, E.1    Xiong, W.J.2    Fourest, E.3    Chan, L.4
  • 22
    • 0025034355 scopus 로고
    • Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science
    • Kasai K, Nakamura Y, White R. Amplification of a variable number of tandem repeats (VNTR) locus (pMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J Forensic Sci. 1990;35:1196-1200.
    • (1990) J Forensic Sci , vol.35 , pp. 1196-1200
    • Kasai, K.1    Nakamura, Y.2    White, R.3
  • 23
    • 0026787565 scopus 로고
    • Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay
    • Reichert WL, Stein JE, French B, Goodwin P, Varanasi U. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay. Carcinogenesis. 1992;13:1475-1479.
    • (1992) Carcinogenesis , vol.13 , pp. 1475-1479
    • Reichert, W.L.1    Stein, J.E.2    French, B.3    Goodwin, P.4    Varanasi, U.5
  • 24
    • 0001769478 scopus 로고    scopus 로고
    • Mixed chimerism after transplantation of allogeneic hematopoietic cells
    • Thomas ED, Blume KG, Forman SJ, eds. Boston, MA: Blackwell Science
    • Storb R, Yu C, McSweeney P. Mixed chimerism after transplantation of allogeneic hematopoietic cells. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. 2nd ed. Boston, MA: Blackwell Science; 1999:287-295.
    • (1999) Hematopoietic Cell Transplantation. 2nd Ed. , pp. 287-295
    • Storb, R.1    Yu, C.2    McSweeney, P.3
  • 25
    • 0034769445 scopus 로고    scopus 로고
    • Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 Tandem Meetings
    • Antin JH, Childs R, Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings (Review). Biol Blood Marrow Transplant. 2001;7:473-485.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 473-485
    • Antin, J.H.1    Childs, R.2    Filipovich, A.H.3
  • 26
  • 27
    • 9144246514 scopus 로고    scopus 로고
    • T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation
    • Baron F, Schaaf-Lafontaine N, Humblet-Baron S, et al. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation. 2003;76:1705-1713.
    • (2003) Transplantation , vol.76 , pp. 1705-1713
    • Baron, F.1    Schaaf-Lafontaine, N.2    Humblet-Baron, S.3
  • 28
    • 10744219960 scopus 로고    scopus 로고
    • Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
    • Maris M, Boeckh M, Storer B, et al. Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. Exp Hematol. 2003;31:941-952.
    • (2003) Exp Hematol , vol.31 , pp. 941-952
    • Maris, M.1    Boeckh, M.2    Storer, B.3
  • 29
    • 0037085790 scopus 로고    scopus 로고
    • Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
    • Junghanss C, Boeckh M, Carter RA, et al. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood. 2002;99:1978-1985.
    • (2002) Blood , vol.99 , pp. 1978-1985
    • Junghanss, C.1    Boeckh, M.2    Carter, R.A.3
  • 30
    • 0037354356 scopus 로고    scopus 로고
    • Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
    • Valcarcel D, Martino R, Caballero D, et al. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2003;31:387-392.
    • (2003) Bone Marrow Transplant , vol.31 , pp. 387-392
    • Valcarcel, D.1    Martino, R.2    Caballero, D.3
  • 31
    • 0842328807 scopus 로고    scopus 로고
    • + dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in solid tumor patients
    • Prepublished on October 9, as DOI 10.1182/blood-2003-04-1170
    • + dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in solid tumor patients. Blood. Prepublished on October 9, 2003, as DOI 10.1182/blood-2003-04-1170. (Now available as Blood. 2004;103: 1560-1563).
    • (2003) Blood
    • Carvallo, C.1    Geller, N.2    Kurlander, R.3
  • 32
    • 0842328807 scopus 로고    scopus 로고
    • + dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in solid tumor patients. Blood. Prepublished on October 9, 2003, as DOI 10.1182/blood-2003-04-1170. (Now available as Blood. 2004;103: 1560-1563).
    • (2004) Blood , vol.103 , pp. 1560-1563
  • 33
    • 0035203549 scopus 로고    scopus 로고
    • G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in non-myeloablated canine recipients: CD3 cells are required
    • Zaucha JM, Zellmer E, Georges G, et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in non-myeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant. 2001;7: 613-619.
    • (2001) Biol Blood Marrow Transplant , vol.7 , pp. 613-619
    • Zaucha, J.M.1    Zellmer, E.2    Georges, G.3
  • 34
    • 0022602179 scopus 로고
    • Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease
    • Hill RS, Petersen FB, Storb R, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986;67:811-816.
    • (1986) Blood , vol.67 , pp. 811-816
    • Hill, R.S.1    Petersen, F.B.2    Storb, R.3
  • 35
    • 0142182271 scopus 로고    scopus 로고
    • Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: Potential predictive value of NK cell chimaerism for late graft rejection
    • Matthes-Martin S, Lion T, Haas OA, et al. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia. 2003;17:1934-1942.
    • (2003) Leukemia , vol.17 , pp. 1934-1942
    • Matthes-Martin, S.1    Lion, T.2    Haas, O.A.3
  • 36
    • 0023552675 scopus 로고
    • Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies
    • Petz LD, Yam P, Wallace RB, et al. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood. 1987;70:1331-1337.
    • (1987) Blood , vol.70 , pp. 1331-1337
    • Petz, L.D.1    Yam, P.2    Wallace, R.B.3
  • 37
    • 85009893939 scopus 로고    scopus 로고
    • Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation
    • Schaap N, Schattenberg A, Mensink E, et al. Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation. Leukemia. 2002;16:13-21.
    • (2002) Leukemia , vol.16 , pp. 13-21
    • Schaap, N.1    Schattenberg, A.2    Mensink, E.3
  • 38
    • 0028206129 scopus 로고
    • Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
    • Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood. 1994;83:3409-3416.
    • (1994) Blood , vol.83 , pp. 3409-3416
    • Mackinnon, S.1    Barnett, L.2    Heller, G.3    O'Reilly, R.J.4
  • 39
    • 10244244934 scopus 로고    scopus 로고
    • Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia
    • Huss R, Deeg HJ, Gooley T, et al. Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant. 1996;18:767-776.
    • (1996) Bone Marrow Transplant , vol.18 , pp. 767-776
    • Huss, R.1    Deeg, H.J.2    Gooley, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.